Flotek Q1 Revenue Up 27% with Data Analytics Soaring 295%, EBITDA +44%
Flotek achieved 27% revenue growth to $70.1M in Q1, led by 295% jump in Data Analytics to $10.4M and 13% rise in Chemistry Technologies to $59.7M. Adjusted EBITDA rose 44% to $9.1M, net income, EPS fell 13% and 29% to $4.7M and $0.12, guidance projects $270M-$290M revenue with $36M-$41M EBITDA.
1. First Quarter Financial Performance
Flotek reported total revenues of $70.1 million for Q1 2026, up 27% from $55.4 million a year earlier. Gross profit rose 25% to $15.5 million, adjusted EBITDA increased 44% to $9.1 million, while net income declined 13% to $4.7 million and EPS fell 29% to $0.12.
2. Data Analytics and Chemistry Segment Growth
Data Analytics revenue surged 295% to $10.4 million, marking its highest quarterly level and contributing 50% of gross profit versus 8% in the prior year. Chemistry Technologies revenue climbed 13% to $59.7 million, its best quarter in over seven years, demonstrating balanced growth across both segments.
3. Strategic Developments and Outlook
Equipment mobilization began on a power services contract, underscoring Flotek’s push into high-margin recurring revenue streams. The XSPCT™ analyzer was named Product of the Year for real-time compositional analysis. Full-year guidance targets $270M–$290M revenue and $36M–$41M adjusted EBITDA, with a Q2–Q4 backlog of $34.1M and a three-year backlog exceeding $90M.